1. Guest, the 'News in Brief' for the week beginning 19th July 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice
  3. Contribute to feedback on the CDC Evidence Review, for more details click here
    Dismiss Notice

trpm3

  1. Sly Saint
    Thread

    The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in ME/CFS patients 2021, Staines et al

    The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic...
    Thread by: Sly Saint, Jul 15, 2021, 0 replies, in forum: BioMedical ME/CFS Research
  2. Andy
    Thread

    Potential therapeutic benefit of Low Dose Naltrexone in [ME/CFS]: Role of Transient Receptor Potential Melastatin 3 ion channels, 2021, Cabanas et al

    Full title: Potential therapeutic benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor...
    Thread by: Andy, Jul 13, 2021, 8 replies, in forum: BioMedical ME/CFS Research
  3. Deleted member 3253
    Thread

    Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in NK cells from ME/CFS patients, Cabanas et al, 2019

    "Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic...
    Thread by: Deleted member 3253, Oct 19, 2019, 47 replies, in forum: BioMedical ME/CFS Research
  4. Andy
    Thread

    Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from CFS/ME, 2019, Cabanas et al

    Background Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (CFS/ME) is a complex multifactorial disorder of unknown cause having multi-system...
    Thread by: Andy, Apr 25, 2019, 51 replies, in forum: BioMedical ME/CFS Research
Showing results 1 to 4 of 4